Client News

Dragonfly Energy’s (NASDAQ: DFLI) CEO, Dr. Denis Phares, is Featured in an Interview with SmallCapsDaily

President & CEO, Dr. Denis Phares, Dives into the Company’s Revolutionary Battery Technology and Sustainable Growth Strategy New York, New York–(Newsfile Corp. – May 16, 2024) – Dragonfly Energy Holdings Corp. (NASDAQ: DFLI) (“the Company”), is excited to announce its CEO, Dr. Denis Phares recently sat down for an interview with SmallCaps Daily. During the interview, […]

Correlate Energy (OTCQB: CIPI) Partners with Energetic Capital To Unlock a Large Untapped Market

BOISE, Idaho, May 15, 2024 (GLOBE NEWSWIRE) — Correlate Energy Corp. (OTCQB: CIPI) (“Correlate” or the “Company”) announces a shared projects pipeline initiative with Energetic Capital aimed at delivering renewable and distributed energy resources into underserved communities. Correlate Energy and Energetic Capital combine forces to leverage Energetic Capital’s innovative financing structure coupled with Correlate Energy’s […]

NanoViricides (NYSE American:NNVC) Has Filed its Quarterly Report

NV-387 Advancing to Phase II Clinical Trial for the Treatment of RSV Infection SHELTON, CT / ACCESSWIRE / May 15, 2024 / NanoViricides, Inc. (NYSE American:NNVC) (the “Company”), a global leader in broad-spectrum antiviral nanomedicines, reports that it has filed its Quarterly Report on Form 10-Q for the fiscal second quarter ending March 31, 2024 with […]

Dragonfly Energy (Nasdaq: DFLI) Reports First Quarter 2024 Financial and Operational Results

Please see the updated press release below, which includes previously omitted tables reconciling non-GAAP financial measures. Dragonfly Energy has continued its expansion into the trucking industry, taking new orders for both its Battle Born® All-Electric APUs and Battle Born® Liftgate Power Systems from fleet operators since the beginning of 2024. The Company is announcing certification of its […]

NanoViricides (NYSE Amer.:NNVC)A Novel Broad-Spectrum Antiviral with Activity Against RSV

Complete Survival of Animals Lethally Infected into Lungs with RSV Achieved Upon NV-387 Oral Treatment SHELTON, CT / ACCESSWIRE / May 14, 2024 / NanoViricides, Inc. (NYSE Amer.:NNVC) (the “Company”), a global leader in broad-spectrum antiviral nanomedicines, says that antiviral activity of NV-387 against RSV/A2 is strong enough to have resulted in full survival of lethally […]

NanoViricides (NYSE American:NNVC) to Participate in the 2024 EF Hutton Annual Global Conference On May 15 in New York City

SHELTON, CT / ACCESSWIRE / May 10, 2024 / NanoViricides, Inc. (NYSE American:NNVC) (the “Company”), a global leader in broad-spectrum antiviral nanomedicines, today announces that Anil R. Diwan, Ph.D., the Company’s President and Executive Chairman, will be attending the EF Hutton Annual Global Conference, which will be held at The Plaza Hotel in New York, NY […]

Amesite (NASDAQ: AMST) Releases New Suite of AI Tools for Job Applications on NurseMagic™ App

35% of Nurses Say They Are “Extremely Likely” to Change Jobs in 2024 DETROIT, May 10, 2024 (GLOBE NEWSWIRE) — Amesite Inc. (NASDAQ: AMST), a leading artificial intelligence software company offering a cloud-based learning platform for business and education markets, today announced the addition of a suite of AI-powered job application tools on the beta NurseMagicTM app. […]

Splash Beverage Group, Inc. (NYSE American: SBEV) Files 8K for Second Tranche of Funding from Its October 5th, 2023 Financing

FORT LAUDERDALE, FL – (NewMediaWire) – May 8, 2024 – Splash Beverage Group, Inc. (NYSE American: SBEV) (“Splash” or the “Company”), a portfolio company of leading beverage brands, today is pleased to announce it closed on the second tranche of funding from its convertible promissory note announced last October. The aggregate gross proceeds from the second […]

Start Expanding
Your Shareholder Base

Let us help you connect with investors
committed to your success.